Drug intelligence / Profile preview

androstenediol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Androstenediol is a naturally occurring steroid hormone that serves as an intermediate in the biosynthesis of testosterone and estrogen. It is produced in the adrenal glands, gonads, and other tissues by the reduction of dehydroepiandrosterone (DHEA). Androstenediol can be converted to testosterone via enzymatic pathways involving hydroxysteroid dehydrogenases. It exhibits weak androgenic activity compared to testosterone but has notable estrogenic effects due to its affinity for estrogen receptors. Historically used as a dietary supplement for purported benefits such as increased energy, muscle growth, enhanced athletic performance, sexual function improvement, and treatment of hypogonadism or delayed puberty in males. However, scientific evidence supporting these uses is limited. Due to concerns about safety and misuse in sports doping (it is banned by WADA), androstenediol was reclassified as a Schedule III controlled substance in the United States; it now requires a prescription[2][3][4][5].

Brand names
Androdiol
Other names
androstene-3beta,17beta-diolandrostènediol1-androstene-3beta,17beta-diol4-androstene 3,17-diolandrostane diol
02

Targets

ESR2 (ERβ)AR (Adrenergic receptors)ESR1 (ERα)

Beyond the preview

Go deeper on androstenediol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on androstenediol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call